In an article by Global News, published on November 2, 2023, groundbreaking research from Canadian experts at the renowned University of Waterloo was showcased. These researchers have been working diligently on a unique and innovative development: a topical cannabis gel designed specifically to alleviate the discomfort from arthritis. Arthritis pain, which affects millions of people worldwide, is a debilitating condition characterized by chronic inflammation and pain in the joints. Currently, the innovative gel is still undergoing its pre-clinical phase, but initial results have been promising. The researchers have tactfully employed the potent power of cannabinoids to develop this gel. Cannabinoids are the primary active components found in cannabis. They are widely recognized for their remarkable anti-inflammatory and pain-relieving properties. When applied topically, these components interact with the body’s endocannabinoid system, which plays a crucial role in maintaining homeostasis in the body, including pain sensation. Interestingly, the blend prepared by the researchers is not limited to cannabinoids. It also incorporates natural elements such as menthol and camphor. Menthol, known for its cooling effect, and camphor, recognized for its warming sensation, both contribute to alleviating localized pain, synergistically enhancing this gel’s potent pain-relieving capacity. To assess the efficacy and safety of this innovative gel, pre-clinical trials were conducted on arthritic mice. The trials went beyond just observing whether the gel alleviated pain. They also investigated whether the gel reduced inflammation significantly and how well the subjects tolerated it. The results were outstanding. Not only did the gel succeed in substantially reducing pain and inflammation, but it was also well-tolerated by the mice, showing minimal to no side effects. With these promising pre-clinical results, the research team is now on the brink of initiating clinical trials on human subjects. This step is crucial, as the success of these trials could firmly position this cannabis-based gel as a groundbreaking, revolutionary treatment for arthritis pain. It’s a significant leap in the right direction, one that could potentially change the lives of countless arthritis sufferers around the globe. The anticipation for the results of these upcoming clinical trials is palpable and extends beyond the borders of Canada. After all, arthritis is not a localized issue; it’s a global problem that afflicts millions of people, causing significant distress and impacting their quality of life. If this gel proves to be safe and efficacious in humans, it could offer a much-anticipated new remedy for arthritis sufferers. This innovative gel could potentially offer a non-invasive, non-systemic, and most importantly, effective solution for managing arthritis pain, an alternative that could help countless individuals regain control over their lives.

In an article by Global News, published on November 2, 2023, Canadian researchers at the University of Waterloo showcased their groundbreaking research on a unique and innovative development: a topical cannabis gel designed specifically to alleviate arthritis discomfort ¹. Arthritis pain is a debilitating condition characterized by chronic inflammation and pain in the joints, affecting millions of people worldwide. The researchers have tactfully employed the potent power of cannabinoids to develop this gel. Cannabinoids are the primary active components found in cannabis, widely recognized for their remarkable anti-inflammatory and pain-relieving properties. When applied topically, these components interact with the body’s endocannabinoid system, which plays a crucial role in maintaining homeostasis in the body, including pain sensation ¹.

The blend prepared by the researchers is not limited to cannabinoids. It also incorporates natural elements such as menthol and camphor. Menthol, known for its cooling effect, and camphor, recognized for its warming sensation, both contribute to alleviating localized pain, synergistically enhancing this gel’s potent pain-relieving capacity ¹.

Pre-clinical trials were conducted on arthritic mice to assess the efficacy and safety of this innovative gel. The trials went beyond just observing whether the gel alleviated pain. They also investigated whether the gel reduced inflammation significantly and how well the subjects tolerated it. The results were outstanding. Not only did the gel succeed in substantially reducing pain and inflammation, but it was also well-tolerated by the mice, showing minimal to no side effects ¹.

With these promising pre-clinical results, the research team is now on the brink of initiating clinical trials on humans ¹. This innovative development could potentially provide a safe and effective alternative treatment for arthritis patients.

Learn more:

1. healthline.com2. health.harvard.edu3. cannamd.com4. medicalnewstoday.com